UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$511M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$419M |
| 3 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$353M |
| 4 |
SPDR Gold Trust
GLD
|
+$285M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$258M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.21B |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$1.14B |
| 3 |
Microsoft
MSFT
|
+$1.08B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$790M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$401M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.78% |
| 2 | Healthcare | 6.25% |
| 3 | Consumer Discretionary | 6.24% |
| 4 | Financials | 5.99% |
| 5 | Communication Services | 4.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NSL
3301
DELISTED
NUVEEN SENIOR INCM FD
NSL
| $1.26M | ﹤0.01% |
268,424
-96,494
| -26% | -$441K |
|
3302
GATX Corp
GATX
$6.27B
| $1.26M | ﹤0.01% |
20,679
-14,567
| -41% | -$876K |
|
|
AUY
3303
DELISTED
Yamana Gold, Inc.
AUY
| $1.26M | ﹤0.01% |
230,672
+116,485
| +102% | +$557K |
|
3304
Cohen & Steers
CNS
$4.3B
| $1.26M | ﹤0.01% |
18,481
-8,024
| -30% | -$484K |
|
3305
Viasat
VSAT
$11.1B
| $1.26M | ﹤0.01% |
32,778
+5,039
| +18% | +$205K |
|
|
IBTX
3306
DELISTED
Independent Bank Group, Inc.
IBTX
| $1.26M | ﹤0.01% |
31,039
+9,110
| +42% | +$295K |
|
3307
PUT
Infosys
INFY
$50.7B
| $1.26M | ﹤0.01% |
130,000
| – | – |
|
3308
State Street SPDR S&P Pharmaceuticals ETF
XPH
$515M
| $1.25M | ﹤0.01% |
29,198
-9
| -0% | -$372 |
|
|
EHI
3309
Western Asset Global High Income Fund
EHI
$178M
| $1.25M | ﹤0.01% |
135,567
-8,532
| -6% | -$74.2K |
|
|
HTT
3310
High Templar Tech Ltd
HTT
$391M
| $1.25M | ﹤0.01% |
737,220
-52,458
| -7% | -$86.8K |
|
3311
CALL
The Mosaic Company
MOS
$7.33B
| $1.25M | ﹤0.01% |
100,000
+9,400
| +10% | +$113K |
|
|
BECN
3312
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $1.25M | ﹤0.01% |
47,443
+43,960
| +1,262% | +$982K |
|
3313
FormFactor
FORM
$9.17B
| $1.25M | ﹤0.01% |
42,602
-149,320
| -78% | -$3.68M |
|
|
OEFA
3314
ALPS O'Shares International Developed Quality Dividend ETF
OEFA
$37.7M
| $1.25M | ﹤0.01% |
55,756
-110,585
| -66% | -$2.36M |
|
3315
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.88B
| $1.25M | ﹤0.01% |
29,274
-1,851
| -6% | -$74.6K |
|
|
RTLR
3316
DELISTED
Rattler Midstream LP Common Units
RTLR
| $1.25M | ﹤0.01% |
128,381
-21,218
| -14% | -$165K |
|
3317
Iovance Biotherapeutics
IOVA
$2.87B
| $1.24M | ﹤0.01% |
45,294
+17,495
| +63% | +$575K |
|
3318
Upbound Group
UPBD
$1.16B
| $1.24M | ﹤0.01% |
44,698
-38,845
| -46% | -$863K |
|
3319
Ameris Bancorp
ABCB
$5.89B
| $1.24M | ﹤0.01% |
52,564
+9,941
| +23% | +$233K |
|
3320
RLI Corp
RLI
$5.89B
| $1.24M | ﹤0.01% |
30,212
-84,926
| -74% | -$3.35M |
|
3321
United Natural Foods
UNFI
$2.85B
| $1.24M | ﹤0.01% |
68,098
-22,833
| -25% | -$342K |
|
|
JHME
3322
DELISTED
John Hancock Multifactor Energy ETF
JHME
| $1.24M | ﹤0.01% |
88,570
+85,570
| +2,852% | +$1.16M |
|
|
GRX
3323
Gabelli Healthcare & Wellness Trust
GRX
$146M
| $1.24M | ﹤0.01% |
123,359
+108,463
| +728% | +$1.07M |
|
3324
James River Group Holdings
JRVR
$217M
| $1.24M | ﹤0.01% |
27,510
-46,477
| -63% | -$1.73M |
|
3325
ICU Medical
ICUI
$4.61B
| $1.24M | ﹤0.01% |
6,705
-3,957
| -37% | -$786K |
|
Similar funds
UBS Group's Q2 2020 Portfolio in Review
As of Q2 2020, UBS Group held 8,813 positions worth $237B, up 12% from $212B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group withdrew a net $17.5B in Q2 2020, closing 776 positions and reducing 4,001 holdings. Its most notable exit was Allergan plc, an estimated $1.21B position sold in full.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, UBS Group opened a new position in Warner Music worth $87.9M.
- UBS Group's largest Q2 2020 buy was Warner Music: 2,981,053 shares worth $87.9M.
- UBS Group added most to Vanguard Morningstar Mid-Cap ETF in Q2 2020, an estimated $511M increase.
- UBS Group's biggest Q2 2020 reduction was iShares US Treasury Bond ETF, cutting an estimated $1.14B.
- UBS Group fully exited Allergan plc in Q2 2020, selling an estimated $1.21B.
- UBS Group's ten largest holdings make up 16% of its $237B portfolio in Q2 2020.
- UBS Group opened 706 new positions and closed 776 in Q2 2020.
- UBS Group's portfolio value rose 12% quarter-over-quarter to $237B.
Based on UBS Group's 13F filing for Q2 2020, filed 31 Jul 2020.